Azalea Capital Announces Sale of Ark Naturals

Azalea Capital is pleased to announce that Ark Naturals (“Ark”), a portfolio investment of The Azalea Fund IV, L.P., has been acquired by Alpine Investors.  Founded in 1996, Ark was an early pioneer in the natural pet health category. The Company’s product line focuses on the health and wellness of pets, all developed in conjunction with leading holistic veterinarians.

During our partnership with Azalea Capital, Ark Naturals grew from a small emerging company to become one of the fastest growing brands in the pet treat marketplace.  Working with Azalea has enabled us to build a dynamic and creative team that is transforming the pet dental and supplement categories.  The new partnership with Antelope, the Consumer Pet Platform of Alpine Investors, will enable us to significantly elevate our national presence as we continue our focus on high quality, functional pet products, with an even more robust focus on innovation.  Michael Stoeckle, CEO

Michael Stoeckle and Ark’s full leadership team will remain with the Company.

Azalea Capital is a private investment firm headquartered in Greenville, SC. Azalea partners with entrepreneurs, management teams, and family-owned companies by providing investment capital and operating expertise to enhance the long-term value and growth prospects for each investment. Azalea’s primary focus is to invest in companies located in the Southern and Midwest regions of the U.S., which operate in the Agriculture, Food, Pet, and Industrial Services markets.

Lincoln International represented Ark in the transaction.

For additional information about Azalea Capital and its family of investment funds, please call or visit our website at www.azaleacapital.com.